Scientific research of the Center for Personalized Medicine in case of cancer: genome-wide sequencing
NewsTo perform genome-wide sequencing in order to search for hereditary causes of cancer in the framework of research work, CPM invites patients with the presence of malignant neoplasms (ZN) to study:
- breast cancer (breast cancer women and men);
- ovary (RY);
- colon;
- stomach;
- endometrium (the body of the uterus);
- pancreas;
- neuroendocrine tumor
The studies include men and women in the presence of the following criteria:
▪️ Permanent registration in Moscow and
▪️ Absence of previously identified mutations in the BRCA 1/2 genes in the case of breast cancer
|
№ |
ZNO |
Indications for oncogenetic research
|
|
1 |
Breast cancer (female) |
- Patient's age < 60 years - Bilateral breast cancer - Breast cancer and breast cancer in the patient or his relatives of the I and / or II degree of kinship - A patient of any age with breast cancer and / or breast cancer with two or more relatives of I or II degree of kinship with neoplasms of the following localizations: colorectal cancer, endometrial cancer, stomach cancer, ovarian cancer, pancreatic cancer, kidney cancer, malignant neoplasms of the biliary tract, brain, multiple polyps of the colon - A case of breast cancer in male blood relatives of I and/or II degree of kinship - Breast cancer (male) |
|
2 |
Ovarian cancer |
|
|
|
||
|
3 |
Colorectal cancer |
Synchronous or metachronous colorectal cancer - Patient's age < 60 years - A patient of any age with colorectal cancer with colon polyps and/or microsatellite instability of a high-grade tumor (MSH-H) - A patient of any age with colorectal cancer with two or more relatives of I or II degree of kinship with neoplasms of the following localizations: colorectal cancer, endometrial cancer, stomach cancer, ovarian cancer, pancreatic cancer, kidney cancer, malignant neoplasms of the biliary tract, brain, multiple polyps of the colon |
|
4 |
Stomach cancer |
- Patient's age < 60 years - A patient of any age with stomach cancer with two or more relatives of I and II degree of kinship with tumors of the following localizations: colorectal cancer, endometrial cancer, stomach cancer, ovarian cancer, pancreatic cancer, kidney cancer, malignant neoplasms of the biliary tract, brain, multiple polyps of the colon |
|
5 |
Endometrial cancer (uterine body) |
- Patient's age < 60 years - A patient of any age with endometrial cancer with two or more relatives of I and II degree of kinship with tumors of the following localizations: colorectal cancer, endometrial cancer, stomach cancer, ovarian cancer, pancreatic cancer, kidney cancer, malignant neoplasms of the biliary tract, brain, multiple polyps of the colon |
|
6 |
Pancreatic cancer |
Everything |
|
7 |
Neuroendocrine primary tumor |
Everything |
To participate in the study (if the specified criteria are available), the patient must have
▫️Passport;
,Policy;
,SNILS;
Conclusion on the results of the study of BRCA1/2 genes in the case of breast cancer;
▫️Extracts from the treatment (histological conclusion, receptor status in breast cancer, description of the scope of treatment).
On the day of treatment, it is necessary to take 3 tubes of peripheral blood (not on an empty stomach, blood collection is paid once) and fill out a voluntary informed consent. The study is performed free of charge, the completion period is 4 months.
Contact phone number: +7 (495) 305 05 50
